Neurology · 2006 · 229 citations · 8 references
Life SciencesNeurologyNeuroscienceDementiaMolecular NeuroscienceNeurodegenerationDementia With Lewy BodiesLewy Body DementiaNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseProtein Aggregation DisordersAggregationAlpha-synuclein AggregationAlpha-synuclein ClearanceAlpha-synuclein MisfoldingLysosomal Protein DegradationParkinson Disease Lysosomal PathologyParkinson Disease Pathology
The synucleinopathies are neurodegenerative disorders defined by inclusions composed of aberrantly fibrillized alpha-synuclein, but factors contributing to this process remain largely unknown. The authors examined the glucocerebrosidase gene in 75 autopsy specimens with different synucleinopathies and identified mutations in 23% of cases of dementia with Lewy bodies, expanding on previous findings in subjects with Parkinson disease. Mutations in this lysosomal protein may interfere with the clearance or promote aggregation of alpha-synuclein.
8
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Ana María Cuervo, Leonidas Stefanis, Ross A. Fredenburg et al. · Science · 2004 · 2K citations
Neuropathology provides clues to the pathophysiology of Gaucher disease
Kondi Wong, Ellen Sidransky, Ajay Verma et al. · Molecular Genetics and Metabolism · 2004 · 460 citations
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
William C. Nichols, Nathan Pankratz, Dena Hernández et al. · The Lancet · 2005 · 454 citations
Glucocerebrosidase mutations in subjects with parkinsonism
Alicia Lwin · Molecular Genetics and Metabolism · 2003 · 373 citations · Full text
Life Sciences, Genetics, Neurology +12